Bio-Rad Laboratories, Inc.
BIO
Rangering i aksjer
#2169
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Aksjekurs
$352.89
Sist synkronisert: 2026-10-16
Markedsverdi
$9.44B
Endring (1 dag)
-3.34%
Endring (1 år)
13.83%
Land
US
Handel Bio-Rad Laboratories, Inc. (BIO)
Kategori
Healthcare
Driftsmargin for Bio-Rad Laboratories, Inc. (BIO)
Driftsmargin per October 2026 TTM: 9.08%
Ifølge Bio-Rad Laboratories, Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 9.08%. Ved slutten av 2023 hadde selskapet en driftsmargin på 12.65%.
Historikk for driftsmargin for Bio-Rad Laboratories, Inc. fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 9.08% | -13.36% |
| 2024 | 10.48% | -17.15% |
| 2023 | 12.65% | -26.54% |
| 2022 | 17.22% | 0.58% |
| 2021 | 17.12% | 3.44% |
| 2020 | 16.55% | 66.67% |
| 2019 | 9.93% | -309.49% |
| 2018 | -4.74% | -187.78% |
| 2017 | 5.40% | 110.12% |
| 2016 | 2.57% | -68.89% |
| 2015 | 8.26% | 19.71% |
| 2014 | 6.90% | -13.21% |
| 2013 | 7.95% | -37.70% |
| 2012 | 12.76% | -10.33% |
| 2011 | 14.23% | -3.46% |
| 2010 | 14.74% | 13.82% |
| 2009 | 12.95% | 24.88% |
| 2008 | 10.37% | 12.11% |
| 2007 | 9.25% | -19.35% |
| 2006 | 11.47% | 17.52% |
| 2005 | 9.76% | -2.30% |
| 2004 | 9.99% | -31.25% |
| 2003 | 14.53% | -5.59% |
| 2002 | 15.39% | 12.34% |
| 2001 | 13.70% | 48.91% |
| 2000 | 9.20% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 17.03% | -98.12% |
US
|
|
| 17.86% | -98.03% |
IE
|
|
| 22.03% | -97.57% |
US
|
|
| 21.46% | -97.64% |
US
|
|
| 0.00% | - |
DE
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.